REGENXBIO Inc. | Ownership
Companies that own REGENXBIO Inc.
BlackRock Fund Advisors
3,954,101
11.31%
1,885,443
0.01%
06/30/2018
RTW Investments LP
2,079,555
5.95%
201,788
8.41%
06/30/2018
The Vanguard Group, Inc.
1,800,430
5.15%
549,963
0%
06/30/2018
Fidelity Management & Research Co.
1,623,794
4.63%
-389,700
0.01%
06/30/2018
Redmile Group LLC
1,561,175
4.46%
-569,797
3.41%
06/30/2018
SSgA Funds Management, Inc.
1,334,224
3.82%
128,875
0.01%
06/30/2018
Water Street Capital, Inc.
1,038,975
2.97%
838,975
2.33%
06/30/2018
Perceptive Advisors LLC
867,106
2.48%
-14,000
1.39%
06/30/2018
Franklin Advisers, Inc.
743,476
2.13%
-25,400
0.04%
06/30/2018
JPMorgan Asset Management (UK) Ltd.
530,620
1.52%
-323,064
0.03%
06/30/2018
| Address |
9600 Blackwell Road
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.regenxbio.com |
| Updated |
07/08/2019 |
| REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. |
